• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体改变可能是癌症风险和结局存在种族特异性差异的基础。

Mitochondrial alterations may underlie race-specific differences in cancer risk and outcome.

机构信息

Barbara Ann Karmanos Cancer Institute, Population Studies and Disparities Research, Wayne State University, Detroit, Michigan, USA.

Department of Medicine, Duke Cancer Institute, Duke University, Durham, North Carolina, USA.

出版信息

J Clin Invest. 2019 May 6;129(6):2187-2188. doi: 10.1172/JCI128707.

DOI:10.1172/JCI128707
PMID:31063989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6546466/
Abstract

African Americans are at increased risk of cancer and associated mortalities compared with European American populations. Socioeconomic, cultural, and biological factors have been implicated in this discrepancy. In this issue of the JCI, Piyarathna et al. identify a set of genes that are upregulated in a number of tumor types in African American cancer patients as compared with European American patients. These genes were associated with enhanced oxidative phosphorylation and upregulation of transcription factors that promote mitochondrial biogenesis, resulting in greater numbers of mitochondria in tumor samples from African American subjects. Together, these results indicate that mitochondria dysfunction may underlie the increased cancer incidence and poor outcomes observed in African American patients.

摘要

与欧洲裔美国人相比,非裔美国人罹患癌症及相关死亡率的风险增加。社会经济、文化和生物学因素与这种差异有关。在本期《临床检查杂志》中,Piyarathna 等人确定了一组基因,与欧洲裔美国人患者相比,这些基因在非裔美国人癌症患者的多种肿瘤类型中上调。这些基因与增强的氧化磷酸化以及促进线粒体生物发生的转录因子的上调有关,导致来自非裔美国受试者的肿瘤样本中线粒体数量增加。总的来说,这些结果表明,线粒体功能障碍可能是非裔美国患者癌症发病率增加和预后不良的基础。

相似文献

1
Mitochondrial alterations may underlie race-specific differences in cancer risk and outcome.线粒体改变可能是癌症风险和结局存在种族特异性差异的基础。
J Clin Invest. 2019 May 6;129(6):2187-2188. doi: 10.1172/JCI128707.
2
ERR1 and PGC1α associated mitochondrial alterations correlate with pan-cancer disparity in African Americans.ERR1 和 PGC1α 相关的线粒体改变与非裔美国人多种癌症的差异相关。
J Clin Invest. 2019 Mar 28;129(6):2351-2356. doi: 10.1172/JCI127579.
3
Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α.骨关节炎软骨细胞中线粒体生物发生受损,但可通过过氧化物酶体增殖物激活受体 γ 共激活因子 1α 逆转。
Arthritis Rheumatol. 2015 May;67(8):2141-53. doi: 10.1002/art.39182.
4
The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.坎格列净这种糖尿病药物通过 AMPK-Sirt1-Pgc-1α 信号通路促进脂肪细胞的线粒体重塑。
Adipocyte. 2020 Dec;9(1):484-494. doi: 10.1080/21623945.2020.1807850.
5
Calcium induces increases in peroxisome proliferator-activated receptor gamma coactivator-1alpha and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation.钙通过一条导致p38丝裂原活化蛋白激酶激活的途径诱导过氧化物酶体增殖物激活受体γ共激活因子-1α增加和线粒体生物发生。
J Biol Chem. 2007 Jun 29;282(26):18793-9. doi: 10.1074/jbc.M611252200. Epub 2007 May 7.
6
The Transcription Factor 7-Like 2-Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Axis Connects Mitochondrial Biogenesis and Metabolic Shift with Stem Cell Commitment to Hepatic Differentiation.转录因子 7 样 2-过氧化物酶体增殖物激活受体 γ 共激活因子 1α 轴将线粒体生物发生和代谢转变与干细胞向肝分化的定向联系起来。
Stem Cells. 2017 Oct;35(10):2184-2197. doi: 10.1002/stem.2688. Epub 2017 Aug 27.
7
PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.PLCε 通过上调 Twist1 调节前列腺癌细胞线粒体氧化代谢和迁移。
J Exp Clin Cancer Res. 2019 Aug 5;38(1):337. doi: 10.1186/s13046-019-1323-8.
8
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.线粒体氧化代谢促成胆管癌中的癌症干细胞表型。
J Hepatol. 2021 Jun;74(6):1373-1385. doi: 10.1016/j.jhep.2020.12.031. Epub 2021 Jan 21.
9
MKP-1 Modulates Mitochondrial Transcription Factors, Oxidative Phosphorylation, and Glycolysis.MKP-1 调节线粒体转录因子、氧化磷酸化和糖酵解。
Immunohorizons. 2020 May 15;4(5):245-258. doi: 10.4049/immunohorizons.2000015.
10
Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis.金属硫蛋白可预防高脂饮食诱导的心脏收缩功能障碍:过氧化物酶体增殖物激活受体γ共激活因子1α及线粒体生物发生的作用
Diabetes. 2007 Sep;56(9):2201-12. doi: 10.2337/db06-1596. Epub 2007 Jun 15.

引用本文的文献

1
Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer.非裔美国膀胱癌患者通过谷氨酰胺代谢激活 OXPHOS 进行线粒体重编程。
JCI Insight. 2024 Sep 10;9(17):e172336. doi: 10.1172/jci.insight.172336.
2
Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions.线粒体在癌症中的失调为治疗干预提供了几个潜在的靶点。
Int J Mol Sci. 2023 Jun 21;24(13):10420. doi: 10.3390/ijms241310420.
3
Polyphenolic Boronates Inhibit Tumor Cell Proliferation: Potential Mitigators of Oxidants in the Tumor Microenvironment.多酚硼酸酯抑制肿瘤细胞增殖:肿瘤微环境中氧化剂的潜在缓解剂
Cancers (Basel). 2023 Feb 8;15(4):1089. doi: 10.3390/cancers15041089.
4
Pathobiological functions and clinical implications of annexin dysregulation in human cancers.膜联蛋白失调在人类癌症中的病理生物学功能及临床意义
Front Cell Dev Biol. 2022 Sep 28;10:1009908. doi: 10.3389/fcell.2022.1009908. eCollection 2022.
5
Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities.肿瘤细胞和肿瘤免疫微环境脆弱性的治疗靶向
Front Oncol. 2022 Jun 8;12:816504. doi: 10.3389/fonc.2022.816504. eCollection 2022.
6
Targeting mitochondrial metabolism for metastatic cancer therapy.针对转移性癌症治疗的靶向线粒体代谢。
Mol Carcinog. 2022 Sep;61(9):827-838. doi: 10.1002/mc.23436. Epub 2022 Jun 20.
7
Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research.利用靶向线粒体药物挖掘肿瘤免疫微环境和免疫代谢:种族差异和癌症结局研究中的挑战与机遇。
FASEB J. 2022 Apr;36(4):e22226. doi: 10.1096/fj.202101862R.

本文引用的文献

1
Current Prevalence of Major Cancer Risk Factors and Screening Test Use in the United States: Disparities by Education and Race/Ethnicity.美国主要癌症风险因素和筛查检测使用的现状:按教育和种族/族裔划分的差异。
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):629-642. doi: 10.1158/1055-9965.EPI-18-1169.
2
ERR1 and PGC1α associated mitochondrial alterations correlate with pan-cancer disparity in African Americans.ERR1 和 PGC1α 相关的线粒体改变与非裔美国人多种癌症的差异相关。
J Clin Invest. 2019 Mar 28;129(6):2351-2356. doi: 10.1172/JCI127579.
3
Breast Cancer Disparities: How Can We Leverage Genomics to Improve Outcomes?乳腺癌差异:我们如何利用基因组学改善治疗结果?
Surg Oncol Clin N Am. 2018 Jan;27(1):217-234. doi: 10.1016/j.soc.2017.07.009.
4
Mitochondrial determinants of cancer health disparities.线粒体与癌症健康差异的关联。
Semin Cancer Biol. 2017 Dec;47:125-146. doi: 10.1016/j.semcancer.2017.05.001. Epub 2017 May 6.
5
Mitochondria and Cancer.线粒体与癌症
Cell. 2016 Jul 28;166(3):555-566. doi: 10.1016/j.cell.2016.07.002.
6
The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications.PGC1α在癌症代谢中的作用及其治疗意义。
Mol Cancer Ther. 2016 May;15(5):774-82. doi: 10.1158/1535-7163.MCT-15-0621. Epub 2016 Apr 15.
7
Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus.二甲双胍对2型糖尿病患者的前列腺癌具有积极的治疗作用。
Am J Med Sci. 2016 Apr;351(4):416-9. doi: 10.1016/j.amjms.2016.01.013. Epub 2016 Jan 29.
8
Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities.基因组研究时代的自我报告种族/族裔:其对理解健康差异的潜在影响。
Hum Genomics. 2015 Jan 7;9(1):1. doi: 10.1186/s40246-014-0023-x.
9
Targeting mitochondria metabolism for cancer therapy.针对癌症治疗的靶向线粒体代谢。
Nat Chem Biol. 2015 Jan;11(1):9-15. doi: 10.1038/nchembio.1712.
10
High mitochondria content is associated with prostate cancer disease progression.线粒体含量高与前列腺癌的疾病进展有关。
Mol Cancer. 2013 Nov 21;12(1):145. doi: 10.1186/1476-4598-12-145.